-
What Clinicians Want To Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes (Part 4 of a 4-Part Series) - 12/10/2021
2:01:24
-
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma (Part 3 of a 4-Part Series) - 12/10/2021
2:00:27
-
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Hodgkin and Non-Hodgkin Lymphoma (Part 2 of a 4-Part Series) - 12/10/2021
2:01:48
-
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia (Part 1 of a 4-Part Series) - 12/20/2021
2:02:12
-
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Triple-Negative Breast Cancer - 12/9/2021
1:47:14
-
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of HER2-Positive Breast Cancer - 12/8/2021
2:00:35
-
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of ER-Positive Breast Cancer - 12/7/2021
1:44:48
-
Optimizing Biomarker-Based Decision-Making for Patients with Non-Small Cell Lung Cancer with EGFR Mutations or with Other Oncogene-Addicted Lung Cancers - 11/11/2021
1:02:33
-
Key Considerations in the Management of Patients with Small Cell Lung Cancer - 11/4/2021
1:02:34
-
Optimizing Biomarker-Based Decision-Making for Patients with Non-Small Cell Lung Cancer with EGFR Mutations or with Other Oncogene-Addicted Lung Cancers - 10/26/2021
1:05:01
-
Identifying, Managing and Mitigating Therapy-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma - 10/4/21
59:54
- Next Page
